Publicacións (28) Publicacións nas que participase algún/ha investigador/a

2007

  1. A thermodynamic study of β-N-acetylhexosaminidase enzyme heterogeneity in cerebrospinal fluid from patients with multiple sclerosis

    Upsala Journal of Medical Sciences, Vol. 112, Núm. 3, pp. 296-302

  2. Angiotensin type-1-receptor antagonists reduce 6-hydroxydopamine toxicity for dopaminergic neurons

    Neurobiology of Aging, Vol. 28, Núm. 4, pp. 555-567

  3. Cardiovascular disease risk in subjects with type 2 diabetes mellitus in a population in southern Spain

    Diabetes Research and Clinical Practice, Vol. 76, Núm. 3, pp. 436-444

  4. Cefalea en la infancia y la adolescencia: aportaciones basadas en la evidencia

    Acta pediátrica española, Vol. 65, Núm. 6, pp. 269-276

  5. Comorbidity in the migraine: Depression, anxiety, stress and insomnia

    Revista de Neurologia, Vol. 45, Núm. 7, pp. 400-405

  6. Diagnostic problems in the initial assessment of epilepsy

    Neurologist, Vol. 13, Núm. 6 SUPPL. 1

  7. Effects of GABA and GABA receptor inhibition on differentiation of mesencephalic precursors into dopaminergic neurons in vitro

    Developmental Neurobiology, Vol. 67, Núm. 12, pp. 1549-1559

  8. Encefalitis aguda diseminada. Leucoencefalitis aguda hemorrágica. Otras enfermedades desmielinizantes

    Medicine, Vol. 9, Núm. 76, pp. 4894-4900

  9. Extenso absceso de tronco resuelto con tratamiento médico

    Neurologia, Vol. 22, Núm. 2, pp. 118-121

  10. Frequency and predictors of symptomatic intracerebral hemorrhage in patients with ischemic stroke treated with recombinant tissue plasminogen activator outside clinical trials

    Cerebrovascular Diseases, Vol. 23, Núm. 2-3, pp. 85-90

  11. Increased body iron stores are associated with poor outcome after thrombolytic treatment in acute stroke

    Stroke, Vol. 38, Núm. 1, pp. 90-95

  12. Infección remota por virus de la hepatitis B y enfermedad desmielinizante multifásica: ¿Casualidad o causalidad?

    Neurologia, Vol. 22, Núm. 8, pp. 542-546

  13. MMP-9 immunoreactivity in acute migraine

    Headache, Vol. 47, Núm. 5, pp. 698-702

  14. Mechanism of 6-hydroxydopamine neurotoxicity: The role of NADPH oxidase and microglial activation in 6-hydroxydopamine-induced degeneration of dopaminergic neurons

    Journal of Neurochemistry, Vol. 103, Núm. 1, pp. 145-156

  15. Mechanisms of interferon-β-induced survival in fetal and neonatal primary astrocytes

    NeuroImmunoModulation, Vol. 14, Núm. 1, pp. 39-45

  16. Música y neurología

    Neurologia, Vol. 22, Núm. 1, pp. 39-45

  17. Prevalence of multiple sclerosis in Santiago de Compostela (Galicia, Spain)

    Multiple Sclerosis, Vol. 13, Núm. 2, pp. 262-264

  18. Recommendations guide for the treatment of migraine in the clinical practice

    Revista Clinica Espanola, Vol. 207, Núm. 4, pp. 190-193

  19. Serotonin decreases generation of dopaminergic neurons from mesencephalic precursors via serotonin type 7 and type 4 receptors

    Developmental Neurobiology, Vol. 67, Núm. 1, pp. 10-22

  20. Serum cellular fibronectin and matrix metalloproteinase-9 as screening biomarkers for the prediction of parenchymal hematoma after thrombolytic therapy in acute ischemic stroke: A multicenter confirmatory study

    Stroke, Vol. 38, Núm. 6, pp. 1855-1859